Friday, July 6, 2018

Pharma finds new and devious ways to pay off FDA advisors and avoid scrutiny

Like delay their payments until after the advisory board meeting, so that it goes undisclosed. Or offer them a high-paying job with the company. Charles Piller has the story in Science.

No comments:

Post a Comment